Sign In
Buy VERV
$11.13
+0 (+0%)
At Close: Oct 24, 2025
The Schall Law Firm Is Investigating Verve Therapeutics Inc And Encourages Investors With Losses To Reach Out
07:00pm, Wednesday, 14'th Aug 2024
LOS ANGELES, CA / ACCESSWIRE / August 14, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Verve Therapeut
The Schall Law Firm Is Probing Verve Therapeutics Inc And Motivates Investors With Losses To Reach Out
11:15pm, Tuesday, 13'th Aug 2024
LOS ANGELES, CA / ACCESSWIRE / August 13, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Verve Therapeut
Verve Therapeutics Inc Is Under Investigation By The Schall Law Firm Which Encourages Investors With Losses To Make Contact
08:30pm, Monday, 12'th Aug 2024
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Verve Therapeutics, Inc. ("Verve" or "the Company") (NASDAQ:VERV
Verve Therapeutics Inc Is Being Probed By The Schall Law Firm Which Urges Investors With Losses To Reach Out
07:00pm, Friday, 09'th Aug 2024
LOS ANGELES, CA / ACCESSWIRE / August 9, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Verve Therapeuti
Verve Therapeutics Inc Is Under Investigation By The Schall Law Firm Which Encourages Investors With Losses To Make Contact
07:30pm, Thursday, 08'th Aug 2024
LOS ANGELES, CA / ACCESSWIRE / August 8, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Verve Therapeuti
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Verve Therapeutics, Inc. (NASDAQ: VERV)
11:38am, Thursday, 08'th Aug 2024
NEW YORK, Aug. 8, 2024 /PRNewswire/ -- Purcell & Lefkowitz LLP announces that it is investigating Verve Therapeutics, Inc. (NASDAQ: VERV) on behalf of the company's shareholders. The investigation see
Verve Therapeutics Inc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - VERV
10:00am, Thursday, 08'th Aug 2024
LOS ANGELES , Aug. 8, 2024 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Verve Therapeutics, Inc. ("Verve" or "the Company") (NASDAQ: VERV) for violations of
Verve Therapeutics (VERV) Reports Q2 Loss, Lags Revenue Estimates
09:40am, Thursday, 08'th Aug 2024
Verve Therapeutics (VERV) came out with a quarterly loss of $0.59 per share versus the Zacks Consensus Estimate of a loss of $0.68. This compares to loss of $0.87 per share a year ago.
Verve Therapeutics Inc Is Being Investigated By The Schall Law Firm, Which Urges Investors With Losses To Reach Out
06:30pm, Wednesday, 07'th Aug 2024
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Verve Therapeutics, Inc. ("Verve" or "the Company") (NASDAQ:VERV
Verve Therapeutics Inc Is Under Investigation By The Schall Law Firm Which Encourages Investors With Losses To Make Contact
05:45pm, Tuesday, 06'th Aug 2024
LOS ANGELES, CA / ACCESSWIRE / August 6, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Verve Therapeuti
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
04:05pm, Friday, 02'nd Aug 2024
BOSTON, Aug. 02, 2024 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage company developing a new class of genetic medicines for cardiovascular disease, today announced that on July 31, 2024, th
Verve Therapeutics Inc Is Under Investigation By The Schall Law Firm Which Encourages Investors With Losses To Make Contact
09:45am, Tuesday, 30'th Jul 2024
LOS ANGELES, CA / ACCESSWIRE / July 30, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Verve Therapeutic
Verve Therapeutics Inc Is Under Investigation By The Schall Law Firm Which Encourages Investors With Losses To Make Contact
11:30pm, Monday, 29'th Jul 2024
LOS ANGELES, CA / ACCESSWIRE / July 29, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Verve Therapeutic
Verve Therapeutics Inc Under Investigation By The Schall Law Firm Encourages Investors With Losses To Reach Out
05:15pm, Friday, 26'th Jul 2024
LOS ANGELES, CA / ACCESSWIRE / July 26, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Verve Therapeutic
Verve Therapeutics Inc Under Investigation By The Schall Law Firm Encourages Investors With Losses To Reach Out
04:30pm, Thursday, 25'th Jul 2024
LOS ANGELES, CA / ACCESSWIRE / July 25, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Verve Therapeutic
